Opendata, web and dolomites

I-DireCT SIGNED

Immune DIREcted and Cancer-selective immunoTherapy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 I-DireCT project word cloud

Explore the words cloud of the I-DireCT project. It provides you a very rough idea of what is the project "I-DireCT" about.

immunomodulatory    training    antibodies    pivotal    doctorate    optimal    secondments    bilateral    industry    assume    oncology    hereby    generation    bispecific    release    physical    restricted    hereto    expanding    central    sciences    carefully    disciplines    translate    immunology    designed    carry    discoveries    science    immunostimulatory    expertise    combines    scientists    array    tumor    immune    formulations    biomedical    generate    edge    months    bio    immunotherapeutic    optimized    stage    scientific    immunotherapy    active    appointed    young    checkpoints    uniquely    drug    material    ideas    sectoral    antibody    nanotech    innovative    timed    fosters    academic    core    eid    ranging    outstanding    esr    chemistry    industrial    multidisciplinary    engineering    18    operations    inter    cancer    direct    commercial    co    issue    immunocytokines    positions    career    immunotherapeutics    revolutionized    disciplinary    off    qualified    network    limits    cutting    academia    additional    breakthrough   

Project "I-DireCT" data sheet

The following table provides information about the project.

Coordinator
ACADEMISCH ZIEKENHUIS GRONINGEN 

Organization address
address: HANZEPLEIN 1
city: GRONINGEN
postcode: 9713 GZ
website: www.umcg.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 2˙533˙358 €
 EC max contribution 2˙533˙358 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-EID
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACADEMISCH ZIEKENHUIS GRONINGEN NL (GRONINGEN) coordinator 929˙669.00
2    INOCURE SRO CZ (PRAHA) participant 587˙178.00
3    Surflay Nanotec GmbH DE (BERLIN) participant 505˙576.00
4    UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT DE (WURZBURG) participant 379˙182.00
5    KAHR MEDICAL LTD IL (JERUSALEM) participant 131˙750.00

Map

 Project objective

I-DireCT is a European Industrial Doctorate (EID) training network designed to provide training and carry out breakthrough research on the rapidly expanding and high impact field of cancer immunotherapy in a carefully integrated academic and inter-sectoral programme. Hereby, we aim to develop next-generation immunotherapeutics and deliver a set of early stage researchers uniquely qualified for a career in academia and/or industry.

Current immunomodulatory antibodies that target pivotal immune checkpoints have revolutionized the field of oncology. However, off-tumor activity limits their application. The objective of I-Direct is to address this issue by 1. developing innovative bispecific antibodies and immunocytokines with tumor-restricted immunostimulatory effects and 2. developing optimized delivery systems to ensure optimal timed release of bio-active drug. Hereto, I-DireCT combines state-of-the-art industrial design of nanotech-based drug formulations with innovative academic and industrial immunotherapeutic concepts into the next-generation of cancer immunotherapeutics.

At the core of I-DireCT is its training objective to offer a cutting-edge multidisciplinary training programme that will enable outstanding young scientists to generate breakthrough ideas and assume leading positions in academia and industry. This training programme includes an array of disciplines, ranging from biomedical sciences (e.g. immunology, antibody engineering) and physical sciences (e.g. chemistry, material science) to drug design & development.

Industrial partners are central to the programme and provide pivotal inter-sectoral expertise on how to translate scientific discoveries into commercial reality, with each ESR being appointed at an inter-sectoral partner for 18 months, as well as through additional secondments. Further, I-Direct will enable long-term multi-disciplinary research and fosters bilateral co-operations between academia and industry.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "I-DIRECT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "I-DIRECT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

i-CONN (2019)

Interdisciplinary connectivity: Understanding and managing complex systems using connectivity science

Read More  

BIGMATH (2018)

Big Data Challenges for Mathematics

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More